Value
6.1/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 7.5 |
| P/S | 7.3 |
| EV/EBITDA | 4.4 |
| Fwd P/E | 8.8 |
| Analyst target | 3.0 |
- ▸Forward P/E: 12.6x
INCY · Why this verdict
Why Incyte (INCY) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score6.8/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The business demonstrates the hallmarks of a high-quality franchise — 31% return on equity, 27% net margins, a Piotroski financial strength score of 9 out of 9, and a wide economic moat — placing it in the top tier of quality within its sector. Quality breakdown | Return on equity should remain above 25% and net margins above 20% over the next four quarters if the quality thesis holds. | →Stable |
| CounterFree cash flow is only 39% of net income — a red flag indicating that reported profitability is converting into cash at a fraction of its stated rate; if cash conversion remains structurally weak, the quality picture is less clean than headline margins alone suggest. | ||
The put-to-call ratio of 3.54 is significantly elevated, reflecting heavy concentration of bearish or protective options positioning that can signal near-term distribution pressure or hedging by large holders; combined with high implied volatility at 68%, the options market is pricing in more downside uncertainty than the underlying fundamental picture alone would suggest. Risk breakdown | The put-to-call ratio should fall below 1.5 for near-term bearish sentiment to be considered resolved and the options-skew concern to be falsified. | →Stable |
| CounterElevated put-to-call ratios are sometimes driven by institutions hedging large long positions rather than expressing directional bearishness — the same ratio that looks like fear can represent protective demand from confident long holders who simply want insurance against a pullback. | ||
The company has beaten earnings estimates in three of its four most recent quarters with an average positive surprise of 18.4%, demonstrating consistent execution against analyst expectations and a management team that tends to deliver above consensus. Catalyst breakdown | Average earnings surprise should remain above 10% per quarter over the next year if the execution thesis remains intact. | →Stable |
| CounterThe one miss in the second-most-recent quarter with a negative surprise can signal emerging inconsistency in the beat streak; if that pattern recurs around earnings, the execution narrative loses force and consensus may become harder to outperform as estimates reset upward. | ||
At a forward price-to-earnings ratio of 11.1x and a PEG ratio of 0.36, the stock screens as attractively valued relative to its earnings growth rate — a combination that suggests room for multiple expansion if the earnings momentum persists. Valuation breakdown | The forward price-to-earnings ratio should expand above 16x over the next 12 months for the valuation re-rating thesis to have materially played out. | →Stable |
| CounterWith strong execution already reflected in the price and the stock near its near-term technical target, the current multiple may already incorporate the near-term earnings upside; the PEG appears low partly because growth estimates may be cyclically elevated relative to a normalized run rate. | ||
The current price sits just below the near-term resistance target with approximately 6% headroom remaining, and the risk/reward gate has failed — the reward-to-risk ratio at current spot does not clear the minimum asymmetry bar, making patience rather than immediate capital addition the appropriate posture. Warnings | A pullback toward the defined entry level near $97.77 would restore the entry geometry and re-open the setup for new capital addition. | →Stable |
| CounterA stock in a confirmed breakout setup — golden cross, above all moving averages, bullish momentum — may not pull back to the entry target before continuing higher; waiting for a textbook entry level risks missing a continuation move in a momentum-driven name. | ||
The business demonstrates the hallmarks of a high-quality franchise — 31% return on equity, 27% net margins, a Piotroski financial strength score of 9 out of 9, and a wide economic moat — placing it in the top tier of quality within its sector.
→StableQuality breakdown
- Expectation
- Return on equity should remain above 25% and net margins above 20% over the next four quarters if the quality thesis holds.
CounterFree cash flow is only 39% of net income — a red flag indicating that reported profitability is converting into cash at a fraction of its stated rate; if cash conversion remains structurally weak, the quality picture is less clean than headline margins alone suggest.
The put-to-call ratio of 3.54 is significantly elevated, reflecting heavy concentration of bearish or protective options positioning that can signal near-term distribution pressure or hedging by large holders; combined with high implied volatility at 68%, the options market is pricing in more downside uncertainty than the underlying fundamental picture alone would suggest.
→StableRisk breakdown
- Expectation
- The put-to-call ratio should fall below 1.5 for near-term bearish sentiment to be considered resolved and the options-skew concern to be falsified.
CounterElevated put-to-call ratios are sometimes driven by institutions hedging large long positions rather than expressing directional bearishness — the same ratio that looks like fear can represent protective demand from confident long holders who simply want insurance against a pullback.
The company has beaten earnings estimates in three of its four most recent quarters with an average positive surprise of 18.4%, demonstrating consistent execution against analyst expectations and a management team that tends to deliver above consensus.
→StableCatalyst breakdown
- Expectation
- Average earnings surprise should remain above 10% per quarter over the next year if the execution thesis remains intact.
CounterThe one miss in the second-most-recent quarter with a negative surprise can signal emerging inconsistency in the beat streak; if that pattern recurs around earnings, the execution narrative loses force and consensus may become harder to outperform as estimates reset upward.
At a forward price-to-earnings ratio of 11.1x and a PEG ratio of 0.36, the stock screens as attractively valued relative to its earnings growth rate — a combination that suggests room for multiple expansion if the earnings momentum persists.
→StableValuation breakdown
- Expectation
- The forward price-to-earnings ratio should expand above 16x over the next 12 months for the valuation re-rating thesis to have materially played out.
CounterWith strong execution already reflected in the price and the stock near its near-term technical target, the current multiple may already incorporate the near-term earnings upside; the PEG appears low partly because growth estimates may be cyclically elevated relative to a normalized run rate.
The current price sits just below the near-term resistance target with approximately 6% headroom remaining, and the risk/reward gate has failed — the reward-to-risk ratio at current spot does not clear the minimum asymmetry bar, making patience rather than immediate capital addition the appropriate posture.
→StableWarnings
- Expectation
- A pullback toward the defined entry level near $97.77 would restore the entry geometry and re-open the setup for new capital addition.
CounterA stock in a confirmed breakout setup — golden cross, above all moving averages, bullish momentum — may not pull back to the entry target before continuing higher; waiting for a textbook entry level risks missing a continuation move in a momentum-driven name.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Incyte is a high-quality franchise with a wide economic moat, excellent returns, and a three-quarter earnings beat streak that supports the bull case, but the current price sits just below the near-term resistance target with approximately 6% headroom remaining and the risk/reward gate has failed — making the setup a hold for existing owners rather than a new entry until a pullback restores a more favorable entry geometry.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
8.5/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 10.0 |
| ROA | 9.3 |
| Gross margin | 6.6 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 9.3 |
| FCF quality | 3.1 |
| Moat | 8.2 |
| Piotroski F | 10.0 |
- ▸Excellent ROE: 31%
- ▸Strong margins: 27%
- ▸Earnings quality RED FLAG: 39% FCF/NI
- ▸Wide economic moat
Growth
8.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 7.7 |
| EPS growth | 10.0 |
- ▸Strong growth: 21% YoY
Momentum
6.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.4 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 7.5 |
| Price target | 4.4 |
| erm sentiment | 4.6 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸Insider selling (low materiality) — $3,688,880 (0.016% of mkt cap)
Peer rank
6.9/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 7.2 |
| quality rank | 8.2 |
| growth rank | 5.6 |
- ▸Superior ROE vs peers
Technical
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.4 |
| support resistance | 1.4 |
| 52w position | 9.5 |
Risk (lower is worse)
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.4 |
| days to cover | 4.6 |
| volatility | 3.5 |
| put call | 10.0 |
| implied vol | 5.3 |
| max pain risk | 3.0 |
| beta | 8.5 |
| debt equity | 6.8 |
- ▸Above max pain $70
- ▸Concentration risks: 2 MED (10-K Item 1A)
Catalyst
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Wide-moat business. Accumulate on weakness.
Engine technical detail
verdict_path:
L4:PATH_E_WIDE_MOAT|ENTRY_STICKY:WITHIN_BANDPassed (6)
- MOMENTUM:6.9>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:22d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-0.9=NEGATIVE
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.89
Upside
-13.4%
Downside
15.0%
Sizing output
STARTER
SetupBreakout — Golden cross, above all MAs, RSI 60, MACD bullish
EdgeCatalyst-Driven — Earnings in 22d with 3/4 beat streak
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The STRONG_BUY_WAIT verdict reflects the ASYMMETRY gate's -0.9=NEGATIVE outcome against Growth at 8.8 and asymmetric R:R of -0.89.
The strongest dimensions are Growth at 8.8, Quality at 8.5, and Momentum at 6.9; the weakest are Technical at 4.1, Insider at 5.0, and Sentiment at 5.7. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.89 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Wide Moat Quality Franchise
Trip ifReturn on equity falls below 20% for 2 consecutive quarters.
- P2Earnings Beat Streak Execution
Trip ifEPS surprise stays below 0% for 2 consecutive quarters.
- P3Attractive Valuation Low Peg
Trip ifForward price-to-earnings ratio expands above 18x, signaling the valuation opportunity has fully re-rated.
- P4Price Near Target Entry Unfavorable
Trip ifPrice advances above $108.13 and sustains above that level for 20 consecutive trading days without a pullback below $100.
- P5Elevated Put Call Options Skew
Trip ifPut-to-call ratio falls below 1.5, confirming the elevated bearish skew has resolved.